Industry & Business

Tag "rare disease"

Shire to buy Baxalta for $32 bn

Drugmaker Shire agreed to acquire Baxalta International Inc after a six-month pursuit with $32bn cash and stock offer that will make it one of the world’s leading rare disease specialists.

Read Full Article

New Subscriber

[contact-form-7 id=”65829″ title=”Subscriber”]


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events